US drugs firm Mylan completes $1.75 billion Strides Arcolab buyout

US generic drug specialist Mylan said Thursday it had completed its $1.75 billion acquisition of a unit of India’s Strides Arcolab, boosting its presence in the high-growth injectable drugs market.

The Pennsylvania-based Mylan confirmed the buyout of Agila Specialities, which makes injectables, with some restructuring of the deal since it was first announced in February.

“The acquisition of Agila will create a global injectables leader, expanding and strengthening Mylan’s  ..